Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
When we chatted last week, I showed you how tech is the single best source for achieving true wealth.
It's literally the only place where you can take a handful of stocks, maybe even just one big winner, and cash out with $1 million in the bank.
Specifically, I revealed how Microsoft Corp. (NASDAQ: MSFT) precisely fit the bill. On its way to grabbing a $1.1 trillion market cap, the stock made savvy investors wealthy.
To put that into perspective, $25,000 worth of MSFT stock in early 1994 would be worth an amazing $1.2 million today.
But Microsoft's run is far from over. Just during the last five years, the company has made a series of shrewd moves that have put it on pace to become a $2 trillion stock.
Simply stated, Microsoft leaves no stone unturned in the search for new growth.
And - as I'll show you today - I see the storied leader doubling in value again in five years or less...
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
